他汀类药物与骨质疏松症的研究进展

下载PDF

导出

摘要随着社会人口的老龄化,骨质疏松症已成为日益严重的危害广大中老年人(尤其是中老年女性)健康的医学和社会问题.目前骨质疏松症的防治药物主要有骨吸收抑制剂及骨形成促进剂两大剂.

作者杜建层冯艳萍庞义存

机构地区河北医科大学第三医院妇产科

出处《河北医药》 CAS 2004年第1期101-102,共2页 Hebei Medical Journal

关键词他汀类药物骨质疏松研究进展药理作用骨代谢

参考文献15

1Wang PS, Solomon DH, Mogun H, at al. HMG-CoA redutase inhibitors and the risk of hip fractures in elder-ly patients. JAMA,2000,283:3211-3216.
2Mundy G, Garrett R, Harris S, et al. Stimulation of bone formation on vitro and in rodents by statins. Science, 1999,286:1946-1949.
3Bauer DC, Black DM, Van der Klift M, et al. Statin use and fracture: a metaanalysis of 8 observational studies. Bone,2001,28(Suppl) :s89.
4Cummings SR, Bauer DC. Do statins prevent both cardiovascular disease and fracture? JAMA,2000,283:3255-3257.
5Sirola J, Honkanen R, Kroger H, et al. Relation of statin use and bone loss: a prospective population-based cohort study in early postmenopausal women.Osteoporos Int,2002,13:537-541.
6Van Staa TP, Wegman S, de Vries F, et al. Use of statins and risk of fractures. JAMA,2001,285:1850-1855.
7Reid R, Hague W, Emberson J, et al. Effect of pravastatin on frequency in the LIPID study:secondary analysis ofa randomised controlled trial. Lancet,2001,357:509-512.
8Ohnaka K, Shimoda S, Nawata H, et al. Pitavastatin enhanced BMP-2 and osteocaclin expression by inhibition of Rho-associated kinase in human osteoblasts. Biochem Biophys Res Commun,2001,287:337-342.
9Phillips BW, Belmonte N, Vemochet C, et al. Compactin enhances osteogenesis in murine embryonic stem cells. Biochem Biophs Res Commun,2001,284:478-484.
10Oxlund H, Dalstra M, Andreassen TT, et al. Statin Given perorally to adult rats increases cancellous bone mass and compressive strength. Clcif Tissue lnt,2001,69:299-304.

河北医药

2004年第1期

内容加载中请稍等...